Correlation Between Inozyme Pharma and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Relay Therapeutics, you can compare the effects of market volatilities on Inozyme Pharma and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Relay Therapeutics.
Diversification Opportunities for Inozyme Pharma and Relay Therapeutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Inozyme and Relay is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Relay Therapeutics go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Relay Therapeutics
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Relay Therapeutics. In addition to that, Inozyme Pharma is 1.27 times more volatile than Relay Therapeutics. It trades about -0.53 of its total potential returns per unit of risk. Relay Therapeutics is currently generating about -0.27 per unit of volatility. If you would invest 564.00 in Relay Therapeutics on September 1, 2024 and sell it today you would lose (94.00) from holding Relay Therapeutics or give up 16.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Relay Therapeutics
Performance |
| Timeline |
| Inozyme Pharma |
| Relay Therapeutics |
Inozyme Pharma and Relay Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Relay Therapeutics
The main advantage of trading using opposite Inozyme Pharma and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |